Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Medera and Novoheart Partner to Develop Patient-Specific Mini-Heart Models for HLHS
Wednesday, June 25, 2025Medera have announced a new collaboration with researchers from the University of California San Diego School of Medicine and the Mayo Clinic
Daiichi Sankyo and AstraZeneca Receive Approval for DATROWAY® in Advanced EGFR-Mutated NSCLC
Tuesday, June 24, 2025Daiichi Sankyo and AstraZeneca have received accelerated approval from the US Food and Drug Administration FDA for DATROWAY datopotamab deruxtecandlnk for the treatment of adult patients
Novo Nordisk Ozempic® Recommended in the EU for Peripheral Arterial Disease in Adults with Type 2 Diabetes
Tuesday, June 24, 2025Novo Nordisk has announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has issued a positive opinion to update the label of Ozempic semaglutide onceweekly based on data from the STRIDE trial
Harbour BioMed Enters into Partnership with Otsuka to Advance Bispecific T-Cell Engager for Autoimmune Diseases
Monday, June 23, 2025Harbour BioMed has entered into a global strategic collaboration with Otsuka Pharmaceutical to develop and commercialise HBM a BCMAxCD bispecific Tcell engager for the treatment of autoimmune diseases
Archeus Technologies Secures FDA Clearance for ART-101 to Treat Prostate Cancer
Saturday, June 21, 2025Archeus Technologies has received clearance from the United States Food and Drug Administration FDA for its Investigational New Drug IND application for ART ART is a novel receptortargeting small molecule designed for both imaging and treatment of pr...
Argenx Gains European Commission Approval for Subcutaneous VYVGART in CIDP Treatment
Saturday, June 21, 2025Argenx SE has received approval from the European Commission EC for VYVGART efgartigimod alfa mg subcutaneous SC injection to treat adults with progressive or relapsing active chronic inflammatory demyelinating polyneuropathy CIDP
Annovis Receives NYSE Approval for Compliance Plan
Friday, June 20, 2025Annovis Bio Inc a latestage clinical drug platform company focused on developing treatments for neurodegenerative conditions such as Alzheimers and Parkinsons disease has confirmed that the New York Stock Exchange
RyboDyn Chosen to Join Lilly Gateway Labs to Drive Next-Generation Immunotherapies
Friday, June 20, 2025RyboDyn Inc a biotechnology firm developing firstinclass immunotherapies targeting the dark proteome has been selected to join Lilly Gateway Labs LGL in San Diego Operated in partnership with Alexandria Real Estate Equities
Lisata Therapeutics and GATC Health Partners to Advance AI-Based Drug Development
Thursday, June 19, 2025Lisata Therapeutics has expanded its partnership with GATC Health This extended collaboration aims to accelerate the drug development process and increase the likelihood of success through the use of advanced AI technologies
Advarra Launches AI Council to Advance Responsible Innovation in Clinical Trials
Thursday, June 19, 2025Advarra has announced the formation of the Council for Responsible Use of AI in Clinical TrialsThis initiative aims to foster collaboration within the life sciences sector focusing on the responsible integration of artificial intelligence AI into cli...
